Multiple Myeloma | What Clinicians Want to Know About Anti-CD38 Antibodies in the Management of Multiple Myeloma (Companion Faculty Lecture)

Research To Practice | Oncology Videos · Oct 9, 2023 · 28m

Featuring a slide presentation and related discussion from Dr Philippe Moreau, including the following topics:

General overview of anti-CD38 antibodies in therapy for multiple myeloma (MM) (0:00)

Anti-CD38 antibodies as part of first-line therapy for transplant-ineligible patients with MM (2:35)

Quadruplet versus triplet induction regimens with anti-CD38 antibodies for newly diagnosed, transplant-eligible patients with MM (7:44)

Clinical trial data with anti-CD38 antibodies for patients with MM at first relapse (13:02)

Treatment options for patients with MM at second relapse and beyond…